McCarthy v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided March 19, 2025·No. 18-1826V·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-1826V Filed: February 21, 2025

* * * * * * * * * * * * * * * HARRY L. MCCARTHY, * * Petitioner, * v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * *

Elizabeth Muldowney, Esq., Sands Anderson PC, Richmond VA, for petitioner. Mark Hellie, Esq., U.S. Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEYS’ FEES AND COSTS1

Roth, Special Master:

On November 29, 2018, Harry L. McCarthy filed a petition for compensation under the National Vaccine Injury Compensation Program2 alleging that he developed brachial plexopathy of his right upper extremity as a result of the influenza (“flu”) vaccine he received in his left deltoid on November 30, 2015. Petition, ECF No. 1. Petitioner seeks an award of interim attorneys’ fees and costs.

I. Procedural History

The petition was filed on November 29, 2018, and the matter was assigned to Special Master Sanders. ECF Nos. 1,4. Petitioner filed medical records thereafter on December 3, 2018, and additional medical records and a statement of completion on January 8, 2019. Petitioner’s Exhibits (“Pet. Ex.”) 1-9, ECF Nos. 7, 9. After respondent identified outstanding medical records

1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned finds that the identified material fits within this definition, such material will be redacted from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). in a status report filed on July 12, 2019, petitioner filed additional records on September 9, 2019. ECF No. 13; Pet. Ex. 10, ECF No. 18.

On November 13, 2019, respondent filed his Rule 4(c) Report recommending against compensation in this matter. ECF No. 21. Thereafter, petitioner filed an expert report and medical literature from Dr. Lawrence Steinman on September 21, 2020. Pet. Ex. 11-35, ECF No. 27-29. Respondent filed a responsive report and medical literature from Dr. Robert Naismith on March 22, 2021. Respondent’s Exhibits (“Resp. Ex.”) A-E, ECF No. 34.

The parties continued exchanging expert reports, with Drs. Steinman and Naismith each filing two supplemental reports. Pet. Ex. 36, ECF No. 36; Resp. Ex. F, ECF No. 40; Pet. Ex. 39, ECF No. 43; Resp. Ex. G, ECF No. 46. Thereafter, an entitlement hearing was scheduled for January 2024. ECF No. 48.

On September 15, 2023, the case was reassigned to the undersigned. ECF No. 54. The entitlement hearing commenced on January 17, 2024. However, at the beginning of the hearing, the parties informed the Court that, after reviewing petitioner’s medical records, respondent’s expert’s opinion had changed from what he had expressed in his reports. Accordingly, the hearing concluded after the direct examination of respondent’s expert, and the parties agreed to proceed by submitting supplemental reports. ECF No. 72.

Respondent filed a supplemental report and medical literature from Dr. Naismith on February 29, 2024, and petitioner filed a supplemental report from Dr. Steinman on April 30, 2024. Resp. Ex. H, ECF No. 76; Pet. Ex. 47, ECF No. 78. The parties then filed a status report on June 17, 2024, proposing that the matter be scheduled for further proceedings. ECF No. 80.

On July 5, 2024, petitioner filed a Motion for Interim Attorneys’ Fees and Costs. Motion for Interim Fees, ECF No. 81. Petitioner requests a total of $100,240.95, representing $60,118.20 in attorneys’ fees and $40,122.75 in costs. Motion for Interim Fees at 9-10. Respondent filed a response on July 19, 2024, deferring to the undersigned to determine whether the statutory requirements and legal standard for an award of interim attorneys’ fees and costs were met. Response, ECF No. 83. Petitioner filed a reply on July 22, 2024, stating that she relies on the information provided in her original motion. Reply, ECF No. 84. Respondent was then ordered to clarify his position on reasonable basis. ECF No. 85. Respondent filed a status report on August 21, 2024, stating that he did not have specific objections regarding reasonable basis and deferring to the Court to determine whether the requirement has been met. ECF No. 87.

This matter is now ripe for determination.

II. Legal Framework

The Vaccine Act permits an award of reasonable attorneys’ fees and other costs. § 15(e)(1). If a petitioner succeeds on the merits of his or her claim, petitioner’s counsel is automatically entitled to reasonable attorneys’ fees. Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013). However, a petitioner need not prevail on entitlement to receive a fee award as long as the petition was brought in “good faith” and there was a “reasonable basis” for the claim to proceed. § 15(e)(1).

2 The Federal Circuit has endorsed the use of the lodestar approach to determine what constitutes “reasonable attorneys’ fees” and “other costs” under the Vaccine Act. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1349 (Fed. Cir. 2008). Under this approach, “an initial estimate of a reasonable attorneys’ fee” is calculated by “multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.” Id. at 1347-48 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). That product is then adjusted upward or downward based on other specific findings. Id.

Special masters have substantial discretion in awarding fees and may adjust a fee request sua sponte, apart from objections raised by respondent and without providing petitioners with notice and opportunity to respond. Sabella v. Sec’y of Health & Human Servs., 86 Fed. Cl. 201, 209 (2009). Special masters need not engage in a line-by-line analysis of petitioner’s fee application when reducing fees. Broekelschen v. Sec’y of Health & Human Servs., 102 Fed. Cl. 719, 729 (2011).

III. Discussion

A. Availability of Interim Fees

Special masters have discretion to award interim fees while the litigation is ongoing if “the cost of litigation has imposed an undue hardship” and there is “a good faith basis for the claim.” Shaw v. Sec’y of Health & Human Servs., 609 F. 3d 1372, 1375 (Fed. Cir. 2010); see Avera, 515 F. 3d at 1352. The court in Avera held that interim fees may be awarded “in appropriate circumstances.” Id. at 1351. The court then listed some circumstances—cases involving “protracted” proceedings and “costly experts”—in which it would be “particularly appropriate” to award interim fees. Id. at 1352.

Free access — add to your briefcase to read the full text and ask questions with AI

McCarthy v. Secretary of Health and Human Services, (uscfc 2025).

McCarthy v. Secretary of Health and Human Services (McCarthy v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related